Anika Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
ANIK on Nasdaq
Location
32 Wiggins Avenue, Bedford, MA

There are no Buy or Sell transactions made by insiders since 11/27/2024

Anika Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cheryl R. Blanchard President, CEO, Director, Director $6.07M Mar 14, 2025
Michael L. Levitz EVP, CFO, Treasurer $1.76M Mar 15, 2024
David Colleran EVP, General Counsel, Corp Sec $1.47M Mar 14, 2025
Stephen D. Griffin Evp, Cfo & Coo $1.4M Jun 3, 2025
Glenn R. Larsen Director $738K Jun 20, 2025
Susan Vogt Director $738K Jun 20, 2025
John B. Henneman III Director $733K Jun 20, 2025
Anne Nunes SVP, Chief Operations Officer $726K Mar 14, 2025
Stephen Richard Director $703K Jun 20, 2025
Sheryl L. Conley Director $625K Jun 20, 2025
Gary P. Fischetti Director $611K Jun 20, 2025
Thomas Finnerty EVP, Human Resources $590K Mar 9, 2022
Jeffery S. Thompson Director $588K Jun 14, 2023
William R. Jellison Director $339K Jun 20, 2025
Joseph H. Capper Director $300K Jun 20, 2025
Ian McLeod VP, CAO and Treasurer $255K Apr 5, 2025
Raymond J. Land Director $226K Jun 16, 2021
James Loerop EVP Business Development $182K Jul 8, 2021

Recent Insider Transactions by Companies or Individuals for Anika Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.